1. http://news.bioon.com.
2. (2R)-4-Oxo-4-[3-(Trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin- 7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine: A Potent, Orally Active Dipeptidyl Peptidase IV Inhibitor for the Treatment of Type 2 Diabetes
3. Unlocking the Potential of Asymmetric Hydrogenation at Merck
4. Yang, L.; Zhao, Y.; Xiang, Y.; Liu, L.; Huang, G.; Long, Z.; Leslie, R. D.; Wang, X.; Zhou, Z. Dipeptidyl peptidase-4 inhibitor sitagliptin preserves islet beta cell function in patients with new-onset latent autoimmune diabetes in adults. Presented at the 49th Annual EASD Meeting, Barcelona, Spain, September 23–27, 2013, OP 19 State of the art of inhibiting DPP-4, 109.